
This PR makes us very proud as we have so much respect for Veterans. 🫡 $TRIP $TRUFF news. @redlightholland x @FilamentHealth newsfilecorp.com/release/304…

A clinical-stage natural psychedelic drug development company. $FLHLF $7QS

This PR makes us very proud as we have so much respect for Veterans. 🫡 $TRIP $TRUFF news. @redlightholland x @FilamentHealth newsfilecorp.com/release/304…

Today, @TheraPsil alongside @SabiMind and @FilamentHealth launched the first wellness-focused & stakeholder-funded psilocybin clinical trial. Psychedelic research is about to change. See full release here: therapsil.ca/press-psilwell-…

.@FilamentHealth has received FDA approval for another clinical trial on its lead drug candidate PEX010. $FLHLF #psilocybin #Veterans #psychedelics mugglehead.com/fda-gives-ano…

Today we announced positive data from a phase 2 study of PEX010 in patients with alcohol use disorder. The study found that after 1 dose of #psilocybin, the mean % of heavy drinking days was reduced by more than 50% over the 12-week observation period. filament.health/news/filamen…

.@benlightburn @FilamentHealth discusses the company’s approach to psychedelic medicine, the case for natural botanical extracts rather than synthetic compounds, and its lead experimental therapy that targets methamphetamine use disorder. thebioreport.podbean.com/e/e…

Today we announced the import of Peruvian coca leaf to our Vancouver R&D facility for the development of a botanical drug candidate to treat ADHD. filament.health/news/filamen…

We're proud to supply our botanical psilocybin drug candidate for this much-needed research into opioid use disorder at @imperialcollege.
A groundbreaking clinical trial will explore the use of psilocybin, the active compound in magic mushrooms, to combat opioid addiction. 🍄 This ‘first in the UK’ study aims to help prevent relapse with the power of psychedelics and psychological support. imperial.ac.uk/news/257294/i…

Today we announced a major expansion of our IP portfolio, with 12 new patents accepted in Australia, 5 in Canada, & 3 in the US. Filament holds a total of 46 allowed patents relating to the development & delivery of naturally-derived psychedelic APIs. filament.health/news/filamen…

Today we announced authorization by both @US_FDA & @GovCanHealth of a Phase 2 clinical trial studying PEX010 for methamphetamine use disorder. This is the first ever clinical trial to study the safety & efficacy of botanical #psilocybin for MAUD. filament.health/news/filamen…

We're pleased to report our Q1 2024 results, including important advancement of our drug development efforts in substance use disorders. filament.health/news/filamen…

Our CEO @benlightburn will be hosting an #AMA with @ceodotca at 12PM ET tomorrow to discuss our latest news and developments. Submit questions for Ben via: ceo.ca/@ceoca_james

We're pleased to report our 2023 year-end results including $2.1 million in revenue + @GovCanHealth approval of a Filament-sponsored Phase 2 clinical trial studying our botanical psilocybin for opioid use disorder at @UBC. filament.health/news/filamen…

We're pleased to announce that Michael Messinger has been appointed to our Board of Directors, bringing over 20 years' experience in biotech finance roles. filament.health/news/filamen…

Join Robert Sassoon for a fireside chat with @FilamentHealth CEO Ben Lightburn on Thursday, April 4th, at 12:00 pm ET. #psychedelics #psychedelictherapy #therapeutics us06web.zoom.us/webinar/regi…

Read about @UCalgary's upcoming study which will examine the effects of our botanical #psilocybin for alcohol use disorder:
Can the power of magic mushrooms overcome the pull of alcohol use disorder? 🍄🍻 An upcoming study based in Canada aims to shed light on the potential for psilocybin’s role in battling the beast that is alcohol addiction. hightimes.com/study/study-ai…

The @UCalgary is about to start a major study on psilocybin-assisted therapy for the treatment of alcoholism. British Columbia’s @FilamentHealth will provide magic mushroom extract needed for the research. $FLHLF #psychedelics #psilocybin mugglehead.com/alberta-unive…